Opioid-induced constipation treatment (unknown specific agent)

· Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opioid-induced constipation treatment (unknown specific agent), covering 2017-08-30 to 2017-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain [Phase 3]

See pricing